Clinicians in Saudi Arabia “Know About” Pharmacogenomics, New Study Finds
Pharmacogenomics, or PGx, is changing medicine worldwide. The idea is simple: the right drug should match a person’s genes. But turning this idea…
-
-
Rethinking Pharmacogenomics with Multi-Omics and AI
For decades, doctors have relied on trial and error to prescribe medications. Two patients with the same condition can respond in completely opposite…
-
10 Pharmacogenomics Startups to Watch in 2025
Pharmacogenomics (PGx) is entering a new phase of growth. What began as a niche offering in clinical genetics is now becoming a critical…
-
Are Prescribers Aware of the Liability Associated With Ignoring PGx FDA Recommendations for Commonly Used Medications?
Dr. Patricia Cammazola doesn’t think so. “Physicians/prescribers are often not aware of the liability associated with not considering PGx FDA recommendations and CPIC…
-
Betelgeuse Is Here. Now Let’s Talk About the Real Problem
But here’s the uncomfortable truth: models like Betelgeuse need a healthcare system that can keep up, and right now, we don’t have one.
-
White-Label Pharmacogenomics: Building B2B Revenue Streams for Testing Companies
Discover the power of White-Label Pharmacogenomics. Learn how testing companies can build new B2B revenue streams with our comprehensive guide.
-
TikTok & DNA Tests: How Social Media is Fueling the Pharmacogenomics Boom
Discover how TikTok and at-home DNA tests are fueling the booming pharmacogenomics industry.
-
Not in Your DNA: The Boundaries of Pharmacogenomics in Personalized Medicine
Pharmacogenomics, a pivotal component in enhancing treatment efficacy and minimizing adverse reactions in personalized medicine, has transcended its origins in pharmacogenetics. It now…
-
Pharmacogenomics and the Pharmaceutical Industry: A New Frontier for Business Leaders
Pharmacogenomics and the Pharmaceutical Industry
-
Building a Sustainable Business Model for Pharmacogenomics in Emerging Markets
Explore strategies for crafting a Sustainable Business Model for Pharmacogenomics in Emerging Markets to revolutionize personalized medicine.
End of content
End of content